VIVS Competitors & Alternatives
Compare VivoSim Labs, Inc. with similar stocks in the same industry
Biotechnology
VIVS
Main Stock$0.28
Tradestie Score
59
Market Cap
$8.35M
Revenue Growth
-0.5%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$16.18
|
$170.45M | - | 49 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$7.23
|
$158.43M | - | 30 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$23.35
|
$154.27M | - | 49 | Compare |
|
CGEN
Compugen Ltd
|
$2.48
|
$149.66M | 6.5 | 43 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$14.56
|
$133.50M | - | 48 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.20
|
$114.01M | - | 49 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$31.68
|
$110.20M | - | 47 | Compare |
|
IRD
Opus Genetics, Inc. Common Stock
|
$5.97
|
$107.83M | - | 39 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.74
|
$97.42M | - | 53 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$12.21
|
$67.94M | - | 43 | Compare |
More VIVS Analysis
Data updated: Sep 15, 2026 | Industry: Biotechnology (SIC 2836)
236 stocks in this industry